Kinetics of Schiff base formation between the cholesterol ozonolysis product 3β-hydroxy-5-oxo-5,6-secocholestan-6-al and phosphatidylethanolamine

Chemistry and Physics of Lipids

Volumn 157, Issue 1, 2009, Pages 51-55

  Bach, D ^a   Wachtel, E ^a   Miller, I R ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Oxidized cholesterol; Phospholipids; Schiff base

Indexed keywords

3 BETA HYDROXY 5 OXO 5,6 SECOCHOLESTAN 6 AL; CHOLESTEROL; DIMYRISTOYL PHOSPHATIDYLETHANOLAMINE; OXYSTEROL; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; SCHIFF BASE; UNCLASSIFIED DRUG;

ABSORPTION SPECTROSCOPY; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; COVALENT BOND; LIGHT SCATTERING; MEMBRANE STRUCTURE; OZONOLYSIS; PHASE TRANSITION; PRIORITY JOURNAL; ROOM TEMPERATURE; TEMPERATURE SENSITIVITY; ULTRAVIOLET SPECTROSCOPY;

ABSORPTION; CELL MEMBRANE; CHOLESTANONES; CHOLESTEROL; ETHANOL; GELS; KINETICS; OZONE; PHOSPHATIDYLETHANOLAMINES; SCHIFF BASES; SECOSTEROIDS; SPECTROPHOTOMETRY, ULTRAVIOLET; WATER;

EID: 57249097133     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2008.09.003     Document Type: Article

References (14)

1. Bieschke J., Zhang Q., Powers E.T., Lerner R.A., and Kelly J.W. Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation. Biochemistry 44 (2005) 4977-4983
2. Pryor W.A., Wang K., and Bernudez E. Cholesterol ozonation products as biomarkers for ozone exposure in rats. Biochem. Biophys. Res. Commun. 188 (1992) 618-623
3. Pulfer M.K., and Murphy R.C. Formation of biologically active oxysterols during ozonolysis of cholesterol present in lung surfactant. J. Biol. Chem. 279 (2004) 26331-26338
4. Sathishkumar K., Murthy S.N., and Uppu R.M. Cytotoxic effects of oxysterols produced during ozonolysis of cholesterol in murine GT1-7 hypothalamic neurons. Free Radic. Res. 41 (2006) 82-88
5. Sathishkumar K., Xi X., Martin R., and Uppu R.M. Cholesterol secoaldehyde, an ozonation product of cholesterol, induces amyloid aggregation and apoptosis in murine GT1-7 hypothalamic neurons. J. Alzheimers Dis. 11 (2007) 261-274
6. Sathishkumar K., Haque M., Perumal T.E., Francis J., and Uppu R.M. A major ozonation product of cholesterol, 3beta-hydroxy-5-oxo-5,6-secocholestan-6-al, induces apoptosis in H9c2 cardiomyoblasts. FEBS Lett. 579 (2005) 6444-6450
7. Stewart C.R., Wilson L.M., Zhang Q., Pham C.L.L., Waddington L.J., Staples M.K., Stapleton D., Kelly J.W., and Howlett G.J. Oxidized cholesterol metabolites found in human atherosclerotic lesions promote apolipoprotein C-II amyloid fibril formation. Biochemistry 46 (2007) 5552-5561
8. Takeuchi C., Galve R., Witter D.P., Wentworth A.D., Troseth R.P., Lerner R.A., and Wentworth Jr. P. Proatherogenic effects of the cholesterol ozonolysis products, atheronal-A and atheronal-B. Biochemistry 45 (2006) 7162-7170
9. Truhlar D.G., and Kohen A. Convex Arrhenius plots and their interpretation. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 848-851
10. van Dijck P.W., de Kruijff B., van Deenen L.L., de Gier J., and Demel R.A. The preference of cholesterol for phosphatidylcholine in mixed phosphatidylcholine-phosphatidylethanolamine bilayers. Biochim. Biophys. Acta 455 (1976) 576-587
11. Wachtel E., Bach D., Epand R.F., Tishbee A., and Epand R.M. A product of ozonolysis of cholesterol alters the biophysical properties of phosphatidylethanolamine membranes. Biochemistry 45 (2006) 1345-1351
12. Wentworth Jr. P., Nieva J., Takeuchi C., Galve R., Wentworth A.D., Dilley R.B., DeLaria G.A., Savem A., Babior B.M., Janda K.D., Eschenmoser A., and Lerner R.A. Evidence for ozone formation in human atherosclerotic arteries. Science 302 (2003) 1053-1056
13. Wrba A., Schweiger A., Schultes V., Jaenicke R., and Zavodszky P. Extremely thermostable D-glyceraldehyde-3-phosphate dehydrogenase from the eubacterium thermotoga maritima. Biochemistry 29 (1990) 7582-7584
14. Zhang Q., Powers E.T., Nieva J., Huff M.E., Dendle M.A., Bieschke J., Glabe C.G., Eschenmoser A., Wentworth Jr. P., Lerner R.A., and Kelly J.W. Metabolite-initiated protein misfolding may trigger Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 4752-4757